Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Curis Inc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CRIS: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3240+8
Shares2.01M3.21M+1.20M (+59.5%)
Value$10.8M$9.81M−$1.02M (−9.5%)

New holders (10)

Institutions that held Curis Inc at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CRIS in Q4 2024
InstitutionSharesValue% of portfolio
Alyeska Investment Group, L.P.198,216$606.5K0.00%
Samsara BioCapital, LLC198,216$606.5K0.08%
Armistice Capital, LLC76,000$232.6K0.01%
Engineers Gate Manager LP21,380$65.4K0.00%
Squarepoint Ops LLC11,564$35.4K0.00%
Wells Fargo & Company310$9490.00%
SBI Securities Co., Ltd.32$980.00%
CBIZ Investment Advisory Services, LLC5$150.00%
BNP Paribas Arbitrage, SA2$60.00%
MPWM Advisory Solutions, LLC2$60.00%

Sold out (2)

Institutions that held Curis Inc at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CRIS in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Kingdon Capital Management, L.L.C.90,000$485.1K
Danske Bank A/S2$11